Potential breakthrough treatment for chronic pain Part of $10m capital raising BioScience Managers achieved a 24.7% IRR in its previous fund – top decile performance of international private equity and venture capital fund managers. 20 February 2015, Melbourne, Australia: Leading healthcare fund manager BioScience Managers has invested $5 million in novel chronic pain treatment company Saluda […]
Saluda Medical secures $10 million in new financing New funding secured for Saluda Medical is set to open the next chapter in commercialising breakthrough treatment of chronic pain. Link here. Friday, 20 February 2015: Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain – […]
Link here. 2014 AIM WINNERS – Best Technology Award. Announced at the AIM Awards ceremony on 9 October 2014.
11 August 2014. Link here. Rex Bionics Plc (AIM: RXB), the developer and manufacturer of hands-free robotic exoskeletons for use wheelchair users, today announces that its Auckland-based subsidiary Rex Bionics Ltd (RBL) has been awarded substantial new grant funding the New Zealand Government to support the research and development of REX 3, the platform […]
5 August 2014. Link here. Rex Bionics Plc (“Rex Bionics” or the “Company”) Maiden Interim Results for the six months ended 31 May 2014 5 August 2014, Rex Bionics Plc (RXB) (formerly Union MedTech Plc) the AIM-listed developer and manufacturer of hands-free robotic exoskeletons for use wheelchair users, today announces its maiden unaudited results for […]
Released 5 August 2014. Link here. Rex Bionics Plc (“Rex Bionics” or the “Company”) Appointment of Crispin Simon as Chief Executive Officer Rex Bionics Plc (AIM: RXB), the developer and manufacturer of hands-free robotic exoskeletons for use wheelchair users, today announces the appointment of Crispin Simon as Chief Executive Officer. Crispin, who has a 25-year […]
Released : 10 July 2014 RNS Number : 8968L Link here. REX to exhibit at the Hamlyn Symposium on Medical Robots Rex Bionics plc (AIM: RXB), the developer and manufacturer of REX products: hands-free robotic exoskeletons for use wheelchair users, announces that it will be exhibiting at the 7th Hamlyn Symposium on Medical Robots, at the […]
May 2, 2014. Link here. Company to be admitted to AIM with a market capitalisation of £25.7 million Union MedTech plc today announces it is to be admitted to the AIM market of the London Stock Exchange with a market capitalisation of £25.7 million. On Admission, the acquisition Union MedTech of REX Bionics Limited (“REX […]
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: